fda glp-1 safety alert october 2025 September 8, 2025: launches an import listing safe manufacturers – Partnership for Safe Medicines Pharmacovigilance analysis of neurological adverse

Otros, ipragliflozin, tofogliflozina y luseogliflozin estn en uso en Japn, y an en desarrollo (ertugliflozin, remogliflozin y sotagliflozina)105,111

Non-oral birth control methods, such as IUDs, implants, the patch, and the ring, are the most reliable options while on GLP-1 medications because they bypass the digestive system entirely

On March 26, the FDA is set to decide on Mercks sotatercept, which would be the first disease-modifying treatment for PAH

This triggers insulin secretion, slows gastric emptying, and promotes satiety through vagal signaling

So unlike a lot of chemicals, these hormones are likely to do what they're supposed to do and not to cause too much trouble